Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.

被引：0
|
作者：
Li, Jieying [1 ]
Song, Kai [1 ]
Feng, Yuanyong [1 ]
Shang, Wei [1 ]
机构：
[1] Univ Affiliat Hosp Qingda, Affiliated Hosp Qingdao, Qingdao, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18001
引用
收藏
页码：E18001 / E18001
页数：1
相关论文
共 50 条
  • [31] Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Colevas, A. Dimitrios
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) : 2644 - 2652
  • [32] Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Specenier, P.
    Rasschaert, M.
    Vroman, Ph
    ORAL ONCOLOGY, 2009, : 93 - 93
  • [33] Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Hitt, R
    Amador, ML
    Quintela-Fandino, M
    Jimeno, A
    del Val, O
    Hernando, S
    Cortes-Funes, H
    CANCER, 2006, 106 (01) : 106 - 111
  • [34] Weekly Docetaxel in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Specenier, Pol
    Rasschaert, Marika
    Vroman, Philippe
    Van den Brande, Jan
    Dyck, Joke
    Schrijvers, Dirk
    Huizing, Manon T.
    Vermorken, Jan B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (05): : 472 - 477
  • [35] Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
    Harrington, Kevin J.
    Soulieres, Denis
    Le Tourneau, Christophe
    Dinis, Jose
    Licitra, Lisa F.
    Ahn, Myung-Ju
    Soria, Ainara
    Machiels, Jean-Pascal H.
    Mach, Nicolas
    Mehra, Ranee
    Burtness, Barbara
    Ellison, Misoo C.
    Cheng, Jonathan D.
    Chirovsky, Diana Romana
    Swaby, Ramona F.
    Cohen, Ezra E. W.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (02): : 171 - 181
  • [36] Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
    Iwaki, Sho
    Kadowaki, Shigenori
    Honda, Kazunori
    Narita, Yukiya
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Ando, Masashi
    Muro, Kei
    Sawabe, Michi
    Suzuki, Hidenori
    Nishikawa, Daisuke
    Beppu, Shintaro
    Terada, Hoshino
    Kishikawa, Toshihiro
    Kawakita, Daisuke
    Hanai, Nobuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 764 - 770
  • [37] CARBOPLATIN, PACLITAXEL AND PEMBROLIZUMAB FOR THE FIRST LINE TREATMENT OF RECURRENT AND/OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Valadez, Angelica
    Welsh, Madeleine
    Kim, Christine
    Johns, Angela
    Algazi, Alain
    Kang, Hyunseok
    Kang, Hyunseok
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A118 - A118
  • [38] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [40] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
12345